Literature DB >> 5307674

An active interferon inducer obtained from Hemophilus influenzae type B.

E De Clercq, T C Merigan.   

Abstract

Mesh:

Substances:

Year:  1969        PMID: 5307674

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  7 in total

1.  Role of interferon in mice in protection against influenza A virus by bacterial ribosomes together with membranal glycoproteins of Klebsiella pneumoniae as adjuvant.

Authors:  D Robert; J P Quillon; B Ivanoff; Y Beaudry; R Fontanges; G Normier; A M Pinel; L D D'hinterland
Journal:  Infect Immun       Date:  1979-11       Impact factor: 3.441

2.  Endotoxin-altering activity in serum of developing chicken embryo: lack of correlation with embryonic susceptibility to injected endotoxin.

Authors:  K B Von Eschen; J A Rudbach; K C Milner
Journal:  Infect Immun       Date:  1973-04       Impact factor: 3.441

3.  Antiviral and interferon-inducing activity of a new glutarimide antibiotic, 9-methylstreptimidone.

Authors:  N Saito; F Suzuki; K Sasaki; N Ishida
Journal:  Antimicrob Agents Chemother       Date:  1976-07       Impact factor: 5.191

4.  Potentiating Effect of Freund's Adjuvant on Interferon Production by Endotoxin or Poly rI*Poly rC.

Authors:  E De Clercq; M R Nuwer; T C Merigan
Journal:  Infect Immun       Date:  1970-07       Impact factor: 3.441

5.  The role of interferon in the protective effect of a synthetic double-stranded polyribonucleotide against intranasal vesicular stomatitis virus challenge in mice.

Authors:  E De Clercq; M R Nuwer; T C Merigan
Journal:  J Clin Invest       Date:  1970-08       Impact factor: 14.808

6.  Methylprednisolone protection against endotoxin in lead-sensitized mice.

Authors:  N M Marecki
Journal:  Infect Immun       Date:  1974-05       Impact factor: 3.441

Review 7.  An Odyssey in antiviral drug development-50 years at the Rega Institute: 1964-2014.

Authors:  Erik De Clercq
Journal:  Acta Pharm Sin B       Date:  2015-11-02       Impact factor: 11.413

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.